First-pass extracted concept

TALENs

Candidate: toolkit itemType: engineering method2 source documents2 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

TALENS, transcription-activator-like effector nucleases

Extracted Explainers

What the tool is doing

TALENs are listed as one of the advanced genetic engineering techniques examined in the review for modifying cellular behaviors and functions in tissue engineering.

Source 1DOI PubMed

What problem it solves

The review positions TALENs as a way to genetically alter cells so engineered tissues can gain improved functionality or physiological relevance.

Source 1DOI PubMed

What it does not solve

The abstract does not provide TALEN-specific performance boundaries. It only states broader field challenges such as stability, scalability, and off-target effects.

Source 1DOI PubMed

Alternatives

The abstract names CRISPR-Cas9 and synthetic biology as adjacent approaches, and later mentions base editing as an emerging technology.

Source 1DOI PubMed

Evidence Snippets

We critically examine the application of advanced genetic engineering techniques, including CRISPR-Cas9, TALENs, and synthetic biology, in modifying cellular behaviors and functions for tissue engineering.

Evidence 1Source 1DOI PubMedprovenance

different editing techniques have emerged based on programmable nucleases such as ZFN or TALENS

Evidence 2Source 2DOIprovenance

Supporting Sources

Source 1review2025MEDDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Source 2primary paper2022Journal of Applied Life Sciences InternationalDOI

1 evidence snippet 0 linked claims

Linked Claims

Claim 1challenge summarysupports2025Source 1DOI PubMed

The review identifies long-term genetic stability, scalability, and off-target effects as challenges for genetically engineered tissues.

Quoted textsource-backed

We address the field's challenges, including long-term genetic stability, scalability, and off-target effects, while also considering the ethical implications and evolving regulatory landscape of genetically engineered tissues.

Claim 2review scope summarysupports2025Source 1DOI PubMed

The review examines CRISPR-Cas9, TALENs, and synthetic biology as genetic engineering approaches for modifying cellular behaviors and functions in tissue engineering.

Quoted textsource-backed

We critically examine the application of advanced genetic engineering techniques, including CRISPR-Cas9, TALENs, and synthetic biology, in modifying cellular behaviors and functions for tissue engineering.